Literature DB >> 27260167

Dissecting the regulation of bile-induced biofilm formation in Staphylococcus aureus.

Dulantha Ulluwishewa1, Liang Wang1, Callen Pereira1, Stephanie Flynn2, Elizabeth Cain1, Stephen Stick3,4, F Jerry Reen2, Joshua P Ramsay1, Fergal O'Gara1,2.   

Abstract

Aspiration of bile into the cystic fibrosis (CF) lung has emerged as a prognostic factor for reduced microbial lung biodiversity and the establishment of often fatal, chronic pathogen infections. Staphylococcus aureus is one of the earliest pathogens detected in the lungs of children with CF, and once established as a chronic infection, strategies for its eradication become limited. Several lung pathogens are stimulated to produce biofilms in vitro in the presence of bile. In this study, we further investigated the effects of bile on S. aureus biofilm formation. Most clinical S. aureus strains and the laboratory strain RN4220 were stimulated to form biofilms with sub-inhibitory concentrations of bovine bile. Additionally, we observed bile-induced sensitivity to aminoglycosides, which we exploited in a bursa aurealis transposon screen to isolate mutants reduced in aminoglycoside sensitivity and augmented in bile-induced biofilm formation. We identified five mutants that exhibited hypersensitivity to bile with respect to bile-induced biofilm formation, three of which carried transposon insertions within gene clusters involved in wall teichoic acid (WTA) biosynthesis or transport. Strain TM4 carried an insertion between the divergently oriented tagH and tagG genes, which encode the putative WTA membrane translocation apparatus. Ectopic expression of tagG in TM4 restored a wild-type bile-induced biofilm response, suggesting that reduced translocation of WTA in TM4 induced sensitivity to bile and enhanced the bile-induced biofilm formation response. We propose that WTA may be important for protecting S. aureus against exposure to bile and that bile-induced biofilm formation may be an evolved response to protect cells from bile-induced cell lysis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27260167     DOI: 10.1099/mic.0.000317

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  5 in total

Review 1.  The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens.

Authors:  Kevin S Gipson; Kourtney P Nickerson; Eliana Drenkard; Alejandro Llanos-Chea; Snaha Krishna Dogiparthi; Bernard B Lanter; Rhianna M Hibbler; Lael M Yonker; Bryan P Hurley; Christina S Faherty
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

2.  The Detection of Bile Acids in the Lungs of Paediatric Cystic Fibrosis Patients Is Associated with Altered Inflammatory Patterns.

Authors:  Jose A Caparrós-Martín; Stephanie Flynn; F Jerry Reen; David F Woods; Patricia Agudelo-Romero; Sarath C Ranganathan; Stephen M Stick; Fergal O'Gara
Journal:  Diagnostics (Basel)       Date:  2020-05-06

3.  Targeting the Achilles' Heel of Multidrug-Resistant Staphylococcus aureus by the Endocannabinoid Anandamide.

Authors:  Ronit Vogt Sionov; Shreya Banerjee; Sergei Bogomolov; Reem Smoum; Raphael Mechoulam; Doron Steinberg
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

4.  Bile Acid Signal Molecules Associate Temporally with Respiratory Inflammation and Microbiome Signatures in Clinically Stable Cystic Fibrosis Patients.

Authors:  Stephanie Flynn; F Jerry Reen; Jose A Caparrós-Martín; David F Woods; Jörg Peplies; Sarath C Ranganathan; Stephen M Stick; Fergal O'Gara
Journal:  Microorganisms       Date:  2020-11-06

Review 5.  Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung.

Authors:  David F Woods; Stephanie Flynn; Jose A Caparrós-Martín; Stephen M Stick; F Jerry Reen; Fergal O'Gara
Journal:  Antibiotics (Basel)       Date:  2021-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.